- Hours
- 1 Contact hours
- Code
- 20-1361329
- Duration
- 0 minutes
Contact Hours:
2.5 Contact hours, including 2.5 Advanced Pharmacology Hours
Author:
Jassin Jouria (MD)
This peer-reviewed course is applicable for the following professions:
Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), CCI Credentialed Specialists, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner
Accreditations:
The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)
State Approvals:
Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-951523; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; New York State Education Department’s State Board for Physical Therapy
Course Description:
This course discusses and provides a general overview of cardiac emergencies, including their etiology, pathophysiology, and management.
Outcomes:
≥ 92% of participants will know the current recommendations and guidelines for managing cardiac emergencies.
Objectives:
After completing this continuing education course, the participant will be able to:
- Formulate the patterns of cardiac disease, epidemiology, and factors directly influencing mortality rates.
- Generalize the latest research findings in the diagnosis of cardiac emergencies.
- Integrate the stages of disease progression with associating presenting symptoms.
- Explain the latest findings and guidelines on care and monitoring for cardiac emergencies.
- Summarize alternative therapy options to improve disease prognosis.
Disclosures:
CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.